GlassScriptPhysician profile
Michelle R Abascal
NPI 1730495490
$549.20
in general payments reported to CMS, 2019-2025
13 companies · $254 in 2025
The $254 reported for 2025 was more than what 92% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.05 · 2022: $51.74 · 2023: $115 · 2024: $41.07 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $146.77 | 2025 | Hemosphere |
| Merck Sharp & Dohme LLC | $126.90 | 2021-2025 | Bridion |
| Edwards Lifesciences Corporation | $65.93 | 2021-2023 | Hemosphere |
| Fisher & Paykel Healthcare INC | $50.19 | 2025 | Fisher & Paykel Healthcare |
| Chiesi USA, INC. | $33.99 | 2022-2023 | Cleviprex |
| Eagle Pharmaceuticals, INC. | $30.00 | 2023-2024 | |
| Haemonetics Corporation | $26.51 | 2025 | Teg5000 Hemostasis Analyzer |
| Heron Therapeutics, INC. | $16.53 | 2021 | |
| Medtronic, INC. | $13.95 | 2023 | Invos |
| Masimo Corporation | $12.61 | 2021 | |
| Acacia Pharma INC | $11.74 | 2021 | |
| Ambu INC. | $7.25 | 2021 | |
| Cvrx, INC. | $6.83 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Abascal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.